NCT02723253: Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer |
|
|
| Completed | 2 | 18 | Europe | Radiotherapy, Tom-OX, Tomudex ®, Eloxatin ® | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Rectal Neoplasms | 01/08 | 02/12 | | |
HEARTO, NCT01348412: Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure |
|
|
| Completed | 2 | 31 | Europe | oxaliplatin, raltitrexed, other intravenous chemotherapy drugs | Centre Georges Francois Leclerc, National Cancer Institute, France, Hospira, now a wholly owned subsidiary of Pfizer | Colorectal Cancer, Liver Metastases | 12/10 | 04/18 | | |
NCT01703910 / 2012-001307-20: Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic |
|
|
| Completed | 2 | 29 | Europe | Arm A chemotherapy, Capecitabine, Cisplatin, Cetuximab, Doxorubicin, Fluorouracil, Gemcitabine, Irinotecan, Topotecan, Mitomycin C, Oxaliplatin, Paclitaxel, Docetaxel, Pemetrexed, Raltitrexed, Sorafenib, Erlotinib, Vinorelbine, Dasatinib, Etoposide, arm B chemotherapy | Centro Nacional de Investigaciones Oncologicas CARLOS III, Hospital Universitario de Fuenlabrada, Grupo Hospital de Madrid, Apices Soluciones S.L. | Adenocarcinoma of Colon, Adenocarcinoma of Rectum, Metastatic Disease | 11/12 | 12/14 | | |
NCT02821559: Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer |
|
|
| Completed | 2 | 37 | Europe | TOMOX, Tomudex-Oxaliplatin, Raltitrexed-Oxaliplatin, Bevacizumab | Centre Hospitalier Universitaire de Besancon, Hospira, now a wholly owned subsidiary of Pfizer | Metastatic Colorectal Cancer | 08/14 | | | |
